What's new? Log in Free sign up

Filing search / Kineta, Inc. / "Cybersecurity"

Search information

Kineta, Inc.

Companies

"Cybersecurity"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

15 results

Newest first Best match first

KANT Kineta, Inc.

Definitive proxy

. Board Oversight of Cybersecurity Risk. Cybersecurity is an important part of our risk management processes and an area of increasing focus for our Board … of Directors and management. Our Audit Committee is responsible for the oversight of risks from cybersecurity threats. At least annually, the Audit

26 Apr 24

4:00pm

KANT Kineta, Inc.

research, clinical trials or manufacturing activities, or misappropriation by third parties (such as through a cybersecurity breach) of Kineta’s trade … an adverse effect on Kineta’s business. The costs of mitigating cybersecurity risks are significant and are likely to increase in the future. These costs

21 Mar 24

4:06pm

KANT Kineta, Inc.

Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Subsidiaries or their financial results or prospects. (ii)Cybersecurity. (i)(x) There has been no material security breach or other compromise

KANT Kineta, Inc.

Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

regarding the Company or its Subsidiaries or their financial results or prospects. (jj) Cybersecurity. (i)(x) There has been no material security

KANT Kineta, Inc.

to perform research, clinical trials or manufacturing activities, or misappropriation by third parties (such as through a cybersecurity breach … . The costs of mitigating cybersecurity risks are significant and are likely to increase in the future. These costs include, but are not limited

31 Mar 23

4:05pm

rr7mp dh31a7epb475p4

Kineta Completes Reverse Merger with Yumanity Therapeutics

yi5eikq3mmkh wyj

Prospectus supplement

Registration of securities issued in business combination transactions (amended)

4 Nov 22

4:49pm

Registration of securities issued in business combination transactions (amended)

24 Oct 22

9:14am

k6njmzgoesdrez4yhwt

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Registration of securities issued in business combination transactions

29 Aug 22

12:00am

Shelf registration

3 Dec 21

4:15pm

Entry into a Material Definitive Agreement

Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis

kiza68m6f gtvq6lk2l

Business combination disclosure

Prev
1
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.